Russell et al. (p. 2122, DOI: 10.1002/ajmg.a.37131) suggests certain patients with Bohring–Opitz syndrome (BOS) should be monitored for Wilms tumors. In her recent publication on Bohring-Opitz Syndrome two of the eight new patients with ASXL1 mutations were diagnosed with bilateral Wilms tumor. Mutations in ASXL1 gene cause Bohring-Opitz Syndrome.
Read here the article: The AMJG sequence: WILMS TUMOR SCREENING RECOMMENDED FOR SOME PATIENTS WITH BOHRING–OPITZ SYNDROME
Bohring-Opitz Syndrome 